Abstract Library
Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.
Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.
ENETS Abstract Search
Introduction: The diagnosis of small intestinal neuroendocrine tumors(SI-NETs) is often delayed due to non-specific symptoms, difficulty imaging, and lack of awareness.
Conference:
Presenting Author: Gould H
Authors: Gould H, Kapish A, Karategos T, Abbas S, Olive S,
Keywords: small intestinal neuroendocrine tumor, investigation, Colonoscopy, CT, presentation, symptoms, Diagnosis,
Introduction: Neuroendocrine tumors (NETs) are heterogeneous cancers, arising mainly from the gastroenteropancreatic tract. Delayed diagnosis and mislabelling are widely recognised internationally in midgut NETs with little data describing how to improve diagnosis times. In 2017, transformation of the South Wales NET Service included a change to a gastroenterology-led service model, alongside education and forming working relationships with gastroenterologists and surgeons.
Conference:
Presenting Author:
Authors: Gould H, Kapish A, Karategos T, Abbas S, Taylor R,
Keywords: midgut NET, midgut neuroendocrine tumor, diagnosis, diagnostic delay, investigation, mislabel, imaging,
#3330 Effects of transplantation related immunosuppression on co-existent neuroendocrine tumors
Introduction: Here we detail our experience of managing patients found with NETs whilst on immunosuppression for a transplanted organ or receiving an organ from a donor with a NET.
Conference: 18th Annual ENETS Concerence (2021)
Presenting Author: Shah H
Authors: Shah H, Faulkes R, Shetty S, Shah T,
Keywords: neuroendocrine tumor, immunosuppression, transplantation,
Introduction: Carcinoid syndrome occurs in 20% patients, presenting with flushing, abdominal pain, diarrhoea, and wheeze. The standard of care for carcinoid syndrome is somatostatin analogues (SSAs) with add-on Creon, codeine and loperamide therapy. Nonetheless, half of patients experience debilitating diarrhoea. Telotristat-ethyl is a peripheral tryptophan-hydroxylase inhibitor approved for treatment of diarrhoea, supported by Phase-3 clinical trials.
Conference: 18th Annual ENETS Concerence (2021)
Presenting Author: Cianci N
Authors: Khanna A, Cianci N, Shah H, Chauhan J, Pipe M,
Keywords: Telotristat, carcinoid syndrome, somatostatin analogues, neuroendocrine tumor,
#2765 Role of Biomarkers in Disease Progression of NET
Introduction: Due to the non specific features of neuroendocrine tumors and lack of diagnostic biomarkers, the diagnosis is usually delayed and almost half of patients presenting with distant metastases
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author: Fatima A